Cardiology

Top Story

DCB approved to treat US patients with PAD

DCB approved to treat US patients with PAD
July 26, 2017

Spectranetics announced that the FDA approved its drug-coated balloon for endovascular treatment of patients with peripheral artery disease and superficial femoral or popliteal lesions.

The DCB (Stellarex) is the third approved for this indication in the United States. Approval was based on the results of the ILLUMENATE pivotal trial, which demonstrated high rates of patency and low rates of clinically driven target lesion revascularization in patients with a wide range of lesion complexity and comorbidities, according to a company press release.

In the Journals

Adverse event rates higher with BVS vs. EES at 2 years

July 26, 2017
Target lesion failure and device thrombosis were more common at 2 years in patients who underwent revascularization with a bioresorbable vascular scaffold compared with…

Phthalates associated with chronic disease in men

July 26, 2017
Men with higher concentrations of total phthalates had a greater risk for CVD, type 2 diabetes and high BP, according to a study published in Environmental Research. …
In the Journals

Permanent pacemaker implantation not linked to poor clinical outcomes

July 26, 2017
According to data published in Circulation: Cardiovascular Interventions, both short- and long-term follow-up for patients who received permanent pacemaker implantation…
In the Journals

Good CV health in young adults leads to bigger brain volume

July 26, 2017
People who keep their hearts healthy when they are in their late teens and 20s, may have larger brains in their 40s and 50s, according to findings recently published in…
More Headlines »
CME

Individualizing Antihypertensive Therapy to Meet Today’s Needs of Patients and Providers

This activity is supported by an educational grant from Allergan, Inc.

High blood pressure is a leading cause of cardiovascular disease and death in the United States and is often called…
More »
Video
Meeting News

VIDEO: Heart failure most deadly complication of type 2 diabetes

July 16, 2017
More »
Resource Centers
Heart in Diabetes

Heart in Diabetes

Video
Meeting News

VIDEO: New NLA president discusses updates to PCSK9 inhibitor recommendations

May 22, 2017
More »
Advertisement
Advertisement